Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Polyrizon Ltd., a Nasdaq-listed biotech company, has completed contracting with all five U.S. clinical sites for its first-in-human trial of NASARIX™, an innovative intranasal hydrogel-based allergy blocker for seasonal allergic rhinitis. This progress marks the study's move into patient pre-screening and enrollment, targeting up to 120 participant…
American Battery Technology (ABAT) just punched through with management calling it its best quarter yet and won back a $115M DOE grant for its Tonopah Flats lithium project. The market is pricing future domestic lithium supply into the stock, but fundamentals still show negative earnings, a burn profile, and high short interest. This is a high-risk…
Daktronics, Inc., a leader in digital display technologies, announced fiscal 2027 first quarter results with a 21.2% increase in diluted EPS to $0.40 on 7.1% sales growth, achieving a 10.6% operating margin. The company maintained a product backlog exceeding $300 million for the sixth straight quarter and ended the quarter with a strong cash positi…
Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, has appointed Tzvi Lev as Head of Sales for the Middle East to spearhead commercial expansion across the Gulf Cooperation Council and Israel. Leveraging Lev's extensive defense, diplomatic, and regional market experience, the company aims to convert its advanced autonomous d…
FuelCell Energy reported Q3 FY2026 results highlighting a substantial increase in its backlog to $3.6 billion driven by new agreements including a major data center power supply contract. The company is progressing its manufacturing facility expansion to target 500 MW annualized capacity by 2028 and aims for positive Adjusted EBITDA by Q4 FY2027. S…
Algoma Steel Group Inc. reports progress on managing the unplanned outage at its Lake Superior Power generating facility. Through interim measures coordinated with Ontario's electricity operator, the company has resumed electric arc furnace production and is pursuing options to repair or replace the affected turbine. Algoma continues to evaluate pr…
Cronos Group Inc. announced an expansion of its Spinach® brand product line, introducing new edible multipacks featuring their first live resin gummy and new vape cartridge flavors. These additions build on Spinach®'s position as Canada's leading edible and vape brand, with planned broader national availability.
Zevra Therapeutics, a commercial-stage biopharmaceutical company focused on rare diseases, announced that its executive leadership will present at three major healthcare investor conferences in New York in September 2026. These presentations aim to update investors on the company's progress and strategic direction. Zevra's lead product targets Niem…
OptimizeRx Corp. has appointed Troy Sarich, an expert in pharmaceutical commercialization and artificial intelligence, as a company advisor. Sarich's extensive experience at Johnson & Johnson and deep expertise in data analytics will help OptimizeRx enhance its healthcare technology solutions, facilitating better engagement between life sciences br…
BridgeBio Pharma announced they will present new late-breaking and longer-term data on oral infigratinib, a drug targeting achondroplasia, at the Annual European Society for Paediatric Endocrinology Meeting 2026. The data include results from the PROPEL 3 randomized controlled trial, longer-term safety and efficacy findings, and ongoing studies in …
Telesat Corporation and Farcast have completed a successful demonstration of Farcast's electronically steered antenna technology using Telesat's LEO 3 test satellite. This milestone validates Farcast's architecture, which reduces size, weight, power, and cost while maintaining performance, and sets the stage for integrating this technology into a f…
Kyntra Bio, a biopharmaceutical company focused on oncology and rare diseases, announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover company developments, including updates on their anemia treatment Roxadustat and Phase 2 ADC therapy FG-3246 for prostate cancer.
Palvella Therapeutics, a clinical-stage biotech company targeting rare skin diseases and vascular malformations, announced CEO Wes Kaupinen’s participation in two healthcare investor conferences in September 2026. The company highlighted its lead candidates, QTORIN™ 3.9% rapamycin anhydrous gel and QTORIN™ pitavastatin, which are investigational th…
Purple Biotech Ltd. announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering tri-specific antibody constructs under its CAPTN-3 platform. This patent strengthens the company's intellectual property protection for its modular multispecific antibody technology designed to accelerate development of cancer i…
Johnson & Johnson reportedly replaced $913 million in lost sales with $2.4 billion of new ones but retained less than half of that benefit. The market is near the 52-week high and technical momentum is soft. Valuation is full (market cap ~$654B, P/E ~31). For traders, that sets up a mid-term short: enter at $273.00, stop at $282.00, target $250.00 …
Berkshire Hathaway CEO Greg Abel said the expansion of AI data centers presents a material growth opportunity for the company’s energy operations. The remarks followed Berkshire’s recent increase in its Alphabet position, which Abel and Chairman Warren Buffett approved three months ago. Abel highlighted the electricity intensity of data centers and…
Simmons First National (SFNC) is a regional bank with a long dividend pedigree and a current share price trading below book. With a quarterly dividend of $0.215 (ex-dividend 09/15/2026), improving loan growth, and a cheap price-to-book of ~0.92, the stock offers a lower-risk entry for a mid-term swing trade. Enter at $22.24, stop at $20.00 and targ…
Edible Garden AG Incorporated has officially regained compliance with Nasdaq’s minimum bid price rule, enabling it to maintain its listing and focus on executing growth strategies including expanding its Webster City facility to manufacture ready-to-drink nutrition products and advancing its Farm-to-Formula® platform.
Fervo Energy’s headline 396 MW power deal with Google validates its technology, but the agreement also crystallizes capital intensity, timing risk and near-term revenue shortfalls that the market may have ignored. With a market cap around $5.8B and 2027 revenue guide down to $60-80M, FRVO looks stretched. This is a high-risk short idea with a clear…
Ollie’s Bargain Outlet shares rose in pre-market trading after the off-price retailer reported fiscal second-quarter results that significantly exceeded earnings expectations. The company delivered a large adjusted EPS beat, raised full-year profitability guidance, and executed sizable share repurchases, even as comparable-store sales declined and …
Fastly reported record Q2 revenue and is translating AI-driven traffic into higher-margin Security and Compute services. The market has punished the shares on short-term volatility and insider sales, creating a tactical long opportunity for patient traders that want to capture platform re-rating over the next 180 trading days.
Lifecore Biomedical has signed a significant agreement to perform tech transfer and commercial manufacturing for a commercially marketed injectable drug product from a global pharmaceutical company. This program, expected to generate revenue starting in 2028, further strengthens Lifecore's late-stage commercial pipeline and expands its customer bas…
uniQure has submitted a Biologics License Application (BLA) to the U.S. FDA and a Marketing Authorisation Application (MAA) to the U.K.'s MHRA for its investigational gene therapy ifezuntirgene inilparvovec (AMT-130) for Huntington's disease. The applications are based on three-year Phase I/II study data showing slowed disease progression and the c…
Hewlett Packard Enterprise shares rose sharply in pre-market trading as investors positioned ahead of the company’s fiscal third-quarter 2026 earnings report. A pair of analyst moves - a Deutsche Bank Buy initiation with a $62 target and a Bank of America price-target increase to $82 - alongside hefty consensus growth expectations and a significant…
Teva Pharmaceutical Industries announced positive topline Phase 2a study results for TEV-408, an investigational anti-IL-15 antibody. The drug showed statistically significant and clinically meaningful prevention of gluten-induced intestinal damage in celiac disease patients, with a favorable safety profile. TEV-408 also demonstrated a reduction in…
